Prevalence and determinants of hypertension in Myanmar - A nationwide cross-sectional study

BMC Public Health

Volumn 16, Issue 1, 2016, Pages

  Bjertness, Marius B ^a   Htet, Aung Soe ^a,b   Meyer, Haakon E ^a,c   Htike, Maung Maung Than ^b   Zaw, Ko Ko ^b   Oo, Win Myint ^d   Latt, Tint Swe ^e   Sherpa, Lhamo Y ^a   Bjertness, Espen ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b DEPARTMENT OF HEALTH   (Myanmar)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d University of Medicine (1)   (Myanmar)

^e University of Medicine 2   (Myanmar)

Author keywords

Alcohol; Body mass index; Hypertension; Myanmar; Nationwide; NCD risk factors; Smoking; Waist circumference

Indexed keywords

ADOLESCENT; ADULT; ADVERSE EFFECTS; BODY MASS; COMPLICATION; CROSS-SECTIONAL STUDY; DRINKING BEHAVIOR; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MYANMAR; OBESITY; PREVALENCE; RISK FACTOR; SMOKING; WAIST CIRCUMFERENCE; YOUNG ADULT;

ADOLESCENT; ADULT; ALCOHOL DRINKING; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYANMAR; OBESITY; PREVALENCE; RISK FACTORS; SMOKING; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84978472604     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-016-3275-7     Document Type: Article

References (39)

1. Gudaro AM, Chhapra IU, Sheikh SA. Impact of Foreign Direct Investment on Economic Growth: A Case Study of Pakistan. J Manag Soc Sci. 2012;8(2):22-30.
2. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases - Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104(22):2746-53.
3. Meng Khoo C, Tai ES. Trends in the incidence and mortality of coronary heart disease in asian pacific region: the Singapore experience. J Atheroscler Thromb. 2014;21 Suppl 1:S2-8.
4. Abbas Q, Akbar S, Nasir AS, Ullah HA, Naseem MA: Impact of Foreign Direct Investment on Gross Domestic Product. Glob J Manag Bus Res. 2011;11(8):35-39.
5. Zaw PPT, Htoo TS, Pham NM, Eggleston K. Disparities in health and health care in Myanmar. Lancet. 2015;386(10008):2053.
6. Wichaidit W, Kaewkungwal J, Sirivichayakul C, Taechaboonsermsak P, Suvithayasiri V. Maternal and child health in a marginalized community along the Thai-Myanmar border. Southeast Asian J Trop Med Public Health. 2011;42(1):152.
7. Shi WZ, Yuan KB, Taylor AA, Dai AY, Pan AX, Gill AT, Wittert AG. Monosodium glutamate is related to a higher increase in blood pressure over 5 years: findings from the Jiangsu Nutrition Study of Chinese adults. J Hypertens. 2011;29(5):846-53.
8. Integrated Household Living Conditions Survey in Myanmar (2009-2010). In.: Yangon, Myanmar: IHLCA Project Technical Unit; 2011.
9. Myanmar Health Statistics 2010 [ http://www.moh.gov.mm/file/Myanmar%20Health%20Statistics%202010.pdf ]. Accessed 13 July 2016.
10. Naing C, Aung K. Prevalence and risk factors of hypertension in Myanmar: A systematic review and meta-analysis. Medicine. 2014;93(21):e100.
11. WHO: Noncommunicable disease risk factor survey Myanmar 2009. In. New Delhi: WHO; 2011
12. Sein TT, Myint P, Tin N, Win H, Aye SS, Sein T: The Republic of the Union of Myanmar Health System Review. European Observatory on Health Systems and Policies. 2014;4(3):5.
13. STEPwise approach to noncommunicable disease risk factor surveillance (STEPS) [ http://www.who.int/chp/steps/en/ ]. Accessed 13 July 2016.
14. WHO STEPS Instrument (Core and expanded) [ http://www.who.int/chp/steps/instrument/STEPS-Instrument-V3.1.pdf?ua=1 ]. Accessed 13 July 2016.
15. BMI [ http://apps.who.int/bmi/index.jsp?introPage=intro-3.html ]. Accessed 13 July 2016.
16. Waist circumference and waist-hip ratio [ http://apps.who.int/iris/bitstream/10665/44583/1/9789241501491-eng.pdf ]. Accessed 13 July 2016.
17. Rothman KJGS, Lash TL. Modern Epidemiology. Philadelphia: Lippincott Williams & Wilkins; 2008.
18. Veieroed MLS, Laake P. Medical statistics in clinical and epidemiological research. Oslo: Gyldendal Akademisk; 2012.
19. Søgaard AJ, Selmer R, Bjertness E, Thelle D. The Oslo Health Study: The impact of self-selection in a large, population-based survey. Int J Equity Health. 2004;3:3.
20. Anthony H, Cordesman MK. The Asian Conventional Military Balance 2006. Washington: Center for Strategic and International Studies; 2006.
21. Mohan S, Prabhakaran D, Krishnan A. Promoting populationwide salt reduction in the South-East Asia Region: current status and future directions. Regional Health Forum. 2013;17(1):73.
22. Reddy KS, Katan MB. Diet, nutrition and the prevention of hypertension and cardiovascular diseases. Public Health Nutr. 2004;7(1a):167-86.
23. Karppanen H, Mervaala E. Sodium Intake and Hypertension. Prog Cardiovasc Dis. 2006;49(2):59-75.
24. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens. 2009;23(6):363-84.
25. Ko Ko Z, Tint Swe L, Phyu Phyu A, Thein Gi T, Tin Khine M. Prevalence of Hypertension and Its Associated Factors in the Adult Population in Yangon Division, Myanmar. Asia Pac J Public Health. 2011;23(4):496-506.
26. Anchala R, Khan H, Di Angelantonio E, Kannuri NK, Pant H, Franco OH, Prabhakaran D. Hypertension in India: A systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32(6):1170-7.
27. Aekplakorn W, Putwatana P, Sritara P, Sangthong R, Kessomboon P, Inthawong R, Taneepanichskul S, Sangwatanaroj S, Chariyalertsak S. Changes in prevalence, awareness, treatment and control of hypertension in Thai population, 2004-2009: Thai National Health Examination Survey III-IV. J Hypertens. 2012;30(9):1734-42.
28. Zaman M, Taleb A, Rahman S, Acharyya A, Islam FA, Ahmed M. Prevalence of hypertension among Bangladeshi adult population, A meta-analysis. J Epidemiol Community Health. 2011;65:A405.
29. Gao Y, Tian H, Ran X, Ren Y, Chen T, Chen G, Lin L, Lu J, Weng J, Jia W, et al. Prevalence of Hypertension in China: A Cross-Sectional Study. PLoS One. 2013;8(6):e65938.
30. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005;365(9455):217-23.
31. Kubo K. Myanmar's two decades of partial transition to a market economy: a negative legacy for the new government. Post-Communist Econ. 2013;25(3):357-70.
32. Definition, risk factors, and evaluation of resistant hypertension [ http://www.uptodate.com/contents/definition-risk-factors-and-evaluation-of-resistant-hypertension ?]. Accessed 13 July 2016.
33. Overview of hypertension in adults [ http://www.uptodate.com/contents/overview-of-hypertension-in-adults ?]. Acccessed 13 July 2016.
34. Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012;380(9841):611-9.
35. Wilson P, D'Agostino R, Sullivan L, Parise H, Kannel W. Overweight and obesity as determinants of cardiovascular risk - The Framingham experience. Arch Intern Med. 2002;162(16):1867-72.
36. Chen X, Du H, Zhang J, Chen X, Luo G, Que X, Zhang N, Bian Z, Guo Y, Li L, et al. Adiposity and blood pressure among 55 000 relatively lean rural adults in southwest of China. J Hum Hypertens. 2015;29(9):522-9.
37. Sankar D, Rao MR, Sambandam G, Pugalendi KV. Effect of sesame oil on diuretics or Beta-blockers in the modulation of blood pressure, anthropometry, lipid profile, and redox status. Yale J Biol Med. 2006;79(1):19-26.
38. Huang C, Yu H, Koplan JP. Can China diminish its burden of non-communicable diseases and injuries by promoting health in its policies, practices, and incentives? Lancet. 2014;384(9945):783-92.
39. Dyson PAAD, Fenton B, et al. Successful Up-Scaled Population Interventions to Reduce Risk Factors for Non-Communicable Disease in Adults: Results from the International Community Interventions for Health (CIH) Project in China, India and Mexico. PLoS One. 2015;10(4):e0120941.